Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-004526

Chief Scientific Officer sold 7,540 shares at $25.50 ($192,270)

  • Chief Scientific Officer acquired 7,540 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Zago Wagner M. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-18 Exercise or conversion : show line 1 in the form +7,540 $6.41 $48,331 7,540 D
2021-02-18 Sale : show line 2 in the form −7,540 $25.50 $192,270 0 D
Open-market sales · 7,540 sh · avg $25.50 · $192,270

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-18 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −7,540 $6.41 2023-01-29 7,540 0 D
Loading xslF345X03/doc1.xml…